tradingkey.logo

Amneal Pharmaceuticals Inc <AMRX.OQ> expected to post earnings of 15 cents a share - Earnings Preview

ReutersApr 30, 2025 12:47 PM
  • Amneal Pharmaceuticals Inc AMRX.OQ AMRX.O is expected to show a rise in quarterly revenue when it reports results on May 2 for the period ending March 31 2025

  • The Bridgewater New Jersey-based company is expected to report a 8.5% increase in revenue to $715.487 million from $659.19 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for Amneal Pharmaceuticals Inc is for earnings of 15 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Amneal Pharmaceuticals Inc is $11.50​, above​ its last closing price of $7.75. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

0.15

0.15

0.12

Missed

-21.3

Sep. 30 2024

0.13

0.14

0.16

Beat

18.5

Jun. 30 2024

0.13

0.14

0.16

Beat

15.5​

Mar. 31 2024

0.09

0.09

0.14

Beat

52.2

​​Dec. 31 2023

0.09

0.09

0.14

Beat

55.2

Sep. 30 2023

0.16

0.13

0.19

Beat

49.8​

Jun. 30 2023

0.11

0.11

0.19

Beat

79.2

Mar. 31 2023

0.10

0.10

0.12

Beat

25

This summary was machine generated April 30 at 12:47 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI